| Year |
Citation |
Score |
| 2020 |
Feldmann DP, Heyza J, Zimmermann CM, Patrick SM, Merkel OM. Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy. Molecules (Basel, Switzerland). 25. PMID 32344513 DOI: 10.3390/Molecules25081994 |
0.367 |
|
| 2020 |
Conner KL, Shaik AN, Ekinci E, Kim S, Ruterbusch JJ, Cote ML, Patrick SM. HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer. Dna Repair. 87: 102802. PMID 31981740 DOI: 10.1016/J.Dnarep.2020.102802 |
0.336 |
|
| 2018 |
Heyza J, Lei W, Watza D, Zhang H, Chen W, Back JB, Schwartz AG, Bepler G, Patrick SM. Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30538112 DOI: 10.1158/1078-0432.Ccr-18-3094 |
0.345 |
|
| 2018 |
Heyza JR, Arora S, Zhang H, Conner KL, Lei W, Floyd AM, Deshmukh RR, Sarver J, Trabbic CJ, Erhardt P, Chan TH, Dou QP, Patrick SM. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 10. PMID 30400270 DOI: 10.3390/Nu10111644 |
0.751 |
|
| 2018 |
Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers. 10. PMID 30279363 DOI: 10.3390/Cancers10100368 |
0.739 |
|
| 2017 |
Sawant A, Floyd AM, Dangeti M, Lei W, Sobol RW, Patrick SM. Differential role of base excision repair proteins in mediating cisplatin cytotoxicity. Dna Repair. PMID 28110804 DOI: 10.1016/J.Dnarep.2017.01.002 |
0.685 |
|
| 2016 |
Arora S, Heyza J, Zhang H, Kalman-Maltese V, Tillison K, Floyd AM, Chalfin EM, Bepler G, Patrick SM. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget. PMID 27650543 DOI: 10.18632/Oncotarget.12072 |
0.708 |
|
| 2015 |
Sawant A, Kothandapani A, Zhitkovich A, Sobol RW, Patrick SM. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links. Dna Repair. 35: 126-136. PMID 26519826 DOI: 10.1016/J.Dnarep.2015.10.003 |
0.626 |
|
| 2013 |
Kothandapani A, Sawant A, Dangeti VS, Sobol RW, Patrick SM. Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity. Nucleic Acids Research. 41: 7332-43. PMID 23761438 DOI: 10.1093/Nar/Gkt479 |
0.575 |
|
| 2012 |
Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick SM. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Experimental Cell Research. 318: 1973-86. PMID 22721696 DOI: 10.1016/j.yexcr.2012.06.011 |
0.666 |
|
| 2012 |
Turchi JJ, Patrick SM. Targeting the Nucleotide Excision Repair Pathway for Therapeutic Applications Dna Repair in Cancer Therapy. 109-117. DOI: 10.1016/B978-0-12-384999-1.10006-X |
0.62 |
|
| 2011 |
Kothandapani A, Dangeti VS, Brown AR, Banze LA, Wang XH, Sobol RW, Patrick SM. Novel role of base excision repair in mediating cisplatin cytotoxicity. The Journal of Biological Chemistry. 286: 14564-74. PMID 21357694 DOI: 10.1074/Jbc.M111.225375 |
0.579 |
|
| 2010 |
Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. Dna Repair. 9: 745-53. PMID 20418188 DOI: 10.1016/J.Dnarep.2010.03.010 |
0.749 |
|
| 2008 |
Patrick SM, Tillison K, Horn JM. Recognition of cisplatin-DNA interstrand cross-links by replication protein A. Biochemistry. 47: 10188-96. PMID 18729380 DOI: 10.1021/bi800460d |
0.583 |
|
| Show low-probability matches. |
